Valeant stocks fall due to CEO's medical leave

LAVAL, Que. -- Valeant Pharmaceuticals stock fell about 11 per cent on the Toronto Stock Exchange on Tuesday, the first day the market was open since the embattled drug company announced that CEO Michael Pearson took a medical leave of absence.

See Full Article

Shares of Canada's largest drugmaker (TSX:VRX, NYSE:VRX) fell about 10 per cent Monday in New York to close at US$102.14 following its announcement that Pearson was being treated in hospital for pneumonia.

The stock regained some ground overnight but fell even further when regular trade resumed Tuesday.

The shares were down US$1.66 or 1.6 per cent at US$100.48 on the New York Stock Exchange and down C$18.21 or 11.6 per cent from Thursday's close on the TSX, before the holiday weekend.

Valeant announced Monday that Pearson's duties will be shared on an interim basis between Robert Chai-Onn, Valeant's general counsel, as well as board chairman Ari Kellen and chief financial officer Robert Rosiello.

The company, headquartered in Laval, Que., has been facing a series of scandals that have slashed its stock price by more than half since record highs posted in August.

Pearson himself had been facing criticism and recently struck a defiant tone after calls for his dismissal surfaced.

"If the board wants to fire me they are welcome to fire me, but until they do we're going to get through this thing," Pearson told investors during a Dec. 16 webcast.

The company is facing a congressional investigation in the U.S. over its pricing practices and has been forced to revise its 2016 outlook after ending a drug distribution agreement with Philidor, a U.S. mail-order pharmacy.

Valeant said on Dec. 16 that the October split from Philidor caused a big short-term disruption to its business that would reduce its expectations for the fourth quarter and 2015 as a whole.

But Pearson indicated that a new distribution agreement with major U.S. drug store chain Walgreens had set the company back on the road to recovery.

Pearson, 56, joined Valeant in 2008 after a 23-year career with the consulting firm McKinsey & Co., for which he served as head of its global pharmaceutical practice.

He used a string of acquisitions to turn a relatively small business that made generic drugs and chronic illness treatments into a major pharmaceutical company.

Valeant, formerly based in California, combined with Canadian drugmaker Biovail in 2010 and moved the head office to Mississauga, Ont., and later to Laval near Montreal. During those years, it made numerous acquisitions and diversified into new product groups, including the Bausch & Lomb contact lens business.

Its sales climbed from US$2.46 billion in 2011 to an expected US$10.4 billion to US$10.5 billion for this year.



Advertisements

Latest Economic News

  • Canada can end dairy trade dispute with U.S. by ending pricing irritant: Saputo

    Economic CTV News
    MONTREAL -- Canada can preserve its dairy supply management system and resolve its trade dispute with the United States over dairy subsidies by ending its domestic milk ingredient pricing system, the head of Canada's largest dairy processor said Monday. Source
  • Company appeals Churchill rail ruling in year-long attempt to restore service

    Economic CTV News
    WINNIPEG -- The company that owns a broken rail line into Churchill, Man., says it is appealing a federal regulatory ruling that requires it to repair the track. Hudson Bay Railway Co. was ordered last week by the Canadian Transportation Agency to immediately begin repairs to the track, which is the only land link to the subarctic community of 900 people. Source
  • Quarter of seafood sold in Metro Vancouver is mislabelled: researchers

    Economic CTV News
    VANCOUVER -- A new study shows that up to a quarter of the seafood sold in Metro Vancouver is mislabelled, with tilapia masquerading as snapper and catfish passing as cod. Researchers at the University of British Columbia collected 281 samples of fish and other seafood from restaurants and grocery stores, then tested the DNA to determine the true species. Source
  • Saputo urges end to milk ingredients pricing system opposed by U.S.

    Economic CBC News
    Saputo Inc., one of Canada's largest dairy companies, wants to end a domestic milk ingredient pricing system that has angered the United States, chief executive Lino Saputo Jr. said on Monday, showing a rare crack in solidarity among processors and the country's sheltered dairy farmers. Source
  • Proposed class-action lawsuits filed against Bank of Montreal, CIBC's Simplii

    Economic CTV News
    TORONTO -- Proposed class-action lawsuits have been filed against Bank of Montreal and CIBC's direct banking division Simplii Financial over recently disclosed cybersecurity breaches impacting up to 90,000 customers. Law firms Siskinds LLP and JSS Barristers say they have filed the proposed class actions against the two Canadian banks in the Ontario Superior Court of Justice, alleging the institutions failed to establish robust security measures to protect clients' sensitive information. Source
  • South Korea joins Japan in halting Canadian wheat imports after GMO plants found

    Economic CTV News
    CALGARY -- South Korea has joined Japan in suspending trade in Canadian wheat following the discovery of genetically modified plants in southern Alberta. Global Affairs spokesman Jesse Wilson says it's standard protocol in both countries to temporarily close markets in such cases. Source
  • Volvo sets goal of 25% recycled plastics in cars from 2025

    Economic CBC News
    At least 25 per cent of the plastics used in new Volvo car models from 2025 will be from recycled materials, the Chinese-owned company said on Monday in an anti-pollution plan praised by the United Nations. Source
  • Magna plans electric vehicle joint ventures with Chinese company

    Economic CBC News
    Magna International Inc. says it will form two new joint ventures with a Chinese company to engineer and build electric vehicles. The Ontario-based auto parts company and Beijing Electric Vehicle Co. Ltd., a subsidiary of the BAIC Group, are expected to take over an existing BAIC manufacturing facility where the first production vehicles are planned for 2020. Source
  • Morneau didn't break conflict law introducing pension bill: ethics watchdog

    Economic CBC News
    Finance Minister Bill Morneau wasn't in a conflict of interest when he introduced a pension bill in the House of Commons while he still owned shares in his family's pension services company, according to the ethics commissioner. Source
  • Baytex Energy and Raging River Exploration sign $2.8B merger deal

    Economic CBC News
    Baytex Energy Corp. and Raging River Exploration Inc. have signed a $2.8-billion deal to merge in a bid to boost the companies' East Duvernay Shale operations in Alberta. The combined company, which will operate under the Baytex name, is expected to have production of approximately 94,000 barrels of oil equivalent per day from a diverse portfolio of oil assets that includes the Viking, Peace River, Lloydminster and East Duvernay Shale regions in Canada and the Eagle Ford region in Texas. Source